Hemoglobin (Hgb) >=  g/dL (with or without transfusion support)
Hemoglobin (Hgb) <  g/dL without growth factor or transfusion support
Hemoglobin >=  g/dL (transfusion is acceptable to meet this criteria) within  days of treatment initiation and must be independent of hematopoietic growth factor support
Hemoglobin < . g/dL, independent of transfusion or growth factor support
Hemoglobin >=  g/dL (with or without transfusion support)
Hemoglobin >=  g/dL (with or without transfusion support)
Hemoglobin >=  g/dL (with or without transfusion support) within  days prior to start of protocol therapy.
Hemoglobin ?  g/dL, with or without transfusion support
STRATUM A: Hemoglobin >= . g/dL without support of a blood transfusion within  days of the test
STRATUM B: Hemoglobin >= . g/dL without support of a blood transfusion within  days of the test
STRATUM C: Hemoglobin >= . g/dL without support of a blood transfusion within  days of the test
Hemoglobin ? . g/dL without transfusion support within  days prior to study treatment (erythropoietin or darbepoetin permitted)
Hemoglobin (HGB) >=  g/dl without transfusion or growth factor support for at least  week
Hemoglobin >=  g/dL, with or without transfusion support; NOTE: If the patients bone marrow biopsy shows greater than or equal to % plasma cells, hemoglobin >  g/dL (transfusion support or growth factor support is acceptable)
Bone marrow reserve consistent with: hemoglobin >=  g/dL values must be obtained without the need for myeloid growth factor support, platelet or PRBC transfusion support within  days
Requiring blood product support
Hemoglobin concentration >  g/dL (with or without support)
Hemoglobin >= . g/dL without transfusion support within the past  days (erythropoietin or darbepoetin permitted)
Hemoglobin >=  g/dL (with or without support)
Requiring blood product support
Hemoglobin ? g/dL, without transfusion support within  days preceding the lab assessment.
Hemoglobin ?. g/dL with or without transfusion support
Hemoglobin >=  g/dL (Note: no transfusion within  days. Ongoing growth factor support is acceptable if on a stable dose for the past  days), within  days of day .
Requiring blood product support
Requiring blood product support
Hemoglobin > g/dL (without transfusion support within  days from start of leukapheresis)
Screening hematology values of the following: absolute neutrophil count ? /?L, platelets ? ,/?L, hemoglobin ?  g/dL (without transfusion support);
Hemoglobin > . without transfusion support in the past  days
Hemoglobin ? . g/dL with or without transfusion support
Hemoglobin >=  g/dL. No transfusion or growth factor support for one week prior to labs.
Hemoglobin >=  g/dl (transfusion support allowed)
Hemoglobin >=  g/dL without need for hematopoietic growth factor or transfusion support within  days prior to treatment initiation
Hemoglobin >= . g/dl with transfusion support
Hemoglobin >= . g/dL (without transfusion or growth factor support)
Hemoglobin concentration >  g/dL (with or without support)
Hemoglobin >=  g/dL (transfusion support allowed)
Hemoglobin >=  g/dL (without platelet transfusion or myeloid growth factor support within two weeks of screening)
Hemoglobin >= . g/dl (transfusion and/or growth factor support allowed)
Hemoglobin >= .g/dL (without need for transfusion support within  days; growth factor allowed)
Hemoglobin >/= . g/dL without transfusion support
Hemoglobin ?  g/dL, independent of transfusion or growth factor support
Hemoglobin >  mg/dL without need for hematopoetic growth factor or transfusion support
Screening blood counts of the following: Absolute neutrophil count ? /?L, Platelets ? ,/?L, Hemoglobin ?  g/dL (with transfusion support);
Hemoglobin ?  g/dL without need for hematopoietic growth factor or transfusion support
Anemia, defined as hemoglobin < gram per deciliter (g/dL) or > g/dL below lower limit of normal or both; transfusion support or concurrent treatment with erythropoietin stimulating agents is not permitted
Hemoglobin >= . g/dL without transfusion support >  days prior to registration
Hemoglobin ? g/dL(without transfusion support)
